{
  "nctId": "NCT03029702",
  "briefTitle": "Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus",
  "officialTitle": "Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus",
  "protocolDocument": {
    "nctId": "NCT03029702",
    "filename": "Prot_SAP_002.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2018-03-01",
    "uploadDate": "2024-11-06T13:44",
    "size": 752549,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03029702/document/Prot_SAP_002.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "PHASE4"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "SINGLE",
  "enrollmentInfo": {
    "enrollmentCount": 54,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2018-02-28",
    "completionDate": "2023-08-31",
    "primaryCompletionDate": "2023-08-31",
    "firstSubmitDate": "2017-01-19",
    "firstPostDate": "2017-01-24"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Pregnant women beyond 24 weeks of gestation who are scheduled for a 3-hour oral glucose tolerance test.\n\nExclusion Criteria:\n\n* Fetal anomaly\n* Pregestational diabetes\n* GDM diagnosis without a 3-hour OGTT\n* Multifetal gestation\n* Treatment with non-inhaled steroids within 7 days\n* Allergy to glyburide, metformin or sulfa\n* History of severe pulmonary (pulmonary requirement for oxygen therapy or daily treatment for restrictive of obstructive pulmonary disease)\n* Hepatic (LFT's greater than two times of upper normal range)\n* Renal (serum creatinine higher than 1.2 mg/dL) disease\n* History of heart failure or myocardial infarction",
    "healthyVolunteers": false,
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "maximumAge": "45 Years",
    "stdAges": [
      "ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Proportion of Women Who Are Eligible, Screened, Enroll and Remain in the Study",
        "description": "Proportion of women who are eligible, screened, enrolled and remain in the study",
        "timeFrame": "Through study completion, an average of 16 weeks"
      },
      {
        "measure": "Proportion of Participants Who Report Suitability of the Study Procedures",
        "description": "Suitability of the study procedures and interventions to participants assessed through one-on-one qualitative interview",
        "timeFrame": "Through study completion, an average of 16 weeks"
      }
    ],
    "secondary": [
      {
        "measure": "Proportion of Participants With Consistent GDM Mechanism Before and and After Treatment Initiation",
        "timeFrame": "2 weeks after treatment initiation"
      },
      {
        "measure": "Proportion of Women Who Remain on Same Treatment During Study",
        "timeFrame": "Through study completion, an average of 16 weeks"
      },
      {
        "measure": "Maternal Glucose Control",
        "description": "\\>50% fasting below 95 and 1 hour postprandial \\< 140 during the 4 weeks before delivery",
        "timeFrame": "Delivery"
      },
      {
        "measure": "Proportion of Participants Who Deliver by Primary Cesarean",
        "timeFrame": "Delivery"
      },
      {
        "measure": "Proportion of Participants Who Developed Hypertensive Diseases in Pregnancy",
        "timeFrame": "Delivery"
      },
      {
        "measure": "Birthweight",
        "timeFrame": "Delivery"
      },
      {
        "measure": "Neonatal Lean Body Mass",
        "timeFrame": "Within 72 hours of delivery"
      },
      {
        "measure": "Cord Blood Glucose",
        "timeFrame": "Delivery"
      },
      {
        "measure": "Cord Blood C-peptide",
        "timeFrame": "Delivery"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 2,
      "secondaryCount": 9,
      "otherCount": 0,
      "totalCount": 11
    },
    "studyDesign": {
      "phases": [
        "PHASE4"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 94,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-22T02:29:10.377Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}